STAT3 and cancer: Given that IL-6 can activate downstream STAT3, a key oncogene constitutively activated in many cancer including HCCs and contributing to cancer cell proliferation and survival [30, 31] [32, 33] [34, 35], we examined hepatic STAT3 activation in both genotypes 10-month post DEN injection.